"Sumitomo Chemical has decided to provide about 70% of the funds necessary for NanoScent in Israel to develop a rapid diagnostic sensor for COVID-19, using their scent recognition devices.
Sumitomo Chemical believes that the development of rapid diagnostic sensor technology can be applied not only to COVID-19 but also to pandemic measures in areas where future pandemics are anticipated. Sumitomo Chemical made this important decision as its financial support will also contribute to the improvement of basic technology for the next-generation healthcare platform through 'visualization of physical condition'. This platform has been jointly developed with NanoScent since 2019."
Comments